BNC Korea Co., Ltd. (KOSDAQ:256840)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,040.00
+20.00 (0.50%)
Mar 28, 2025, 3:30 PM KST
-48.01%
Market Cap 268.43B
Revenue (ttm) 86.90B
Net Income (ttm) 15.01B
Shares Out 66.44M
EPS (ttm) 222.70
PE Ratio 18.16
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 266,316
Average Volume 244,589
Open 4,020.00
Previous Close 4,020.00
Day's Range 3,970.00 - 4,120.00
52-Week Range 3,575.00 - 7,980.00
Beta 1.19
RSI 45.41
Earnings Date Mar 21, 2025

About BNC Korea

BNC Korea Co., Ltd. engages in the research and development, production, and sale of biomaterials for medicines in South Korea. The company offers BIENOX Inj., temporary reduce glabellar wrinkles associated with corrugator muscle and/or procerus muscle activity; Juvegel, temporary reduce nasolabial folds in adults; Collapleo Plus, a collagen-based material for the supplementation of damaged or deficient ligaments, tendons, muscles, and fascia; HA fillers and skin booster fillers, including Cutegel, Cutegel Lidocaine, FLORE Lidocaine, CUTEGEL-M,... [Read more]

Sector Healthcare
Founded 2007
Employees 213
Stock Exchange KOSDAQ
Ticker Symbol 256840
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.